Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependent

Previous studies have demonstrated that hydrogen sulfide (H(2)S) protects against multiple cardiovascular disease states in a similar manner as nitric oxide (NO). H(2)S therapy also has been shown to augment NO bioavailability and signaling. The purpose of this study was to investigate the impact of...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: King, Adrienne L., Polhemus, David J., Bhushan, Shashi, Otsuka, Hiroyuki, Kondo, Kazuhisa, Nicholson, Chad K., Bradley, Jessica M., Islam, Kazi N., Calvert, John W., Tao, Ya-Xiong, Dugas, Tammy R., Kelley, Eric E., Elrod, John W., Huang, Paul L., Wang, Rui, Lefer, David J.
פורמט: Artigo
שפה:Inglês
יצא לאור: National Academy of Sciences 2014
נושאים:
Biological Sciences
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3939925/
https://ncbi.nlm.nih.gov/pubmed/24516168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1321871111
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים